| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $25.0M | +48.7% |
| SG&A Expense | $18.6M | -10.2% |
| Operating Income | -$43.6M | +35.0% |
| Net Income | -$40.4M | +38.7% |
| EPS (Basic) | -$3.57 | +39.1% |
| EPS (Diluted) | -$3.57 | +39.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.6M | +64.1% |
| Short-term Investments | $26.0M | -56.9% |
| Current Assets | $68.7M | -20.2% |
| Total Assets | $79.0M | -30.3% |
| Current Liabilities | $6.1M | +7.1% |
| Total Liabilities | $10.6M | -5.1% |
| Stockholders' Equity | $68.3M | -33.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.6M | -42.0% |
| Capital Expenditures | $45K | -62.5% |
| Investing Cash Flow | $53.1M | +255.2% |
| Financing Cash Flow | -$91K | -1.1% |
| Free Cash Flow | -$37.6M | -41.5% |